An Alternative Option for Weight and Glycemia Reduction
Sep 19, 2020
Editor: David L. Joffe, BSPharm, CDE, FACA
Author: Nour Salhab, Pharm.D. Candidate, USF College of Pharmacy
GOP hormone infusion could help in reducing patient weight and glucose levels.
Roux-en-Y gastric surgery (RYGB) is known to be the most efficacious treatment for obesity and type 2 diabetes (T2DM). Increased postprandial secretions of Glucagon-like peptide 1 (GLP-1), Oxyntomodulin (OXM), and peptide YY (PYY) are one of the possible mechanisms of weight loss. These gut hormones have a synergistic effect on decreasing food intake and increasing satiety. Previous studies have shown that a continuous subcutaneous infusion of those hormones led to a reduction in total ad libitum energy intake. The purpose of the study was to determine whether the infusion of the GLP-1 agonist, Oxyntomodulin, and peptide YY (GOP) would reduce body weight and improve glycemia....
Agreement to pay later is required for access to the full text of this article. You will be charged only after your use reaches $5.00 (US) of site content. The costs of producing a newsletter like Diabetes in Control have been increasing, which is why we are asking our readers to help support our ability to continue to bring you quality information about diabetes through charging a minimal price to read certain articles. Thank you for helping to support Diabetes in Control.